Pre-made Ansuvimab benchmark antibody ( Whole mAb, anti-Zaire Ebolavirus GP1 therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Ansuvimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP1 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-028-1mg	1mg	3090
GMP-Bios-ab-028-10mg	10mg	Inquiry
GMP-Bios-ab-028-100mg	100mg	Inquiry
GMP-Bios-ab-028-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Ansuvimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP1 therapeutic antibody
INN Name	Ansuvimab
Target	Zaire Ebolavirus GP1
Format	Whole mAb
Derivation
Species Reactivity	Human
CH1 Isotype	IgG1
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Approved
Est. Status	Active
100% SI Structure	None
99% SI Structure	5fha:HL/5fhc:HL
95-98% SI Structure	None
Year Proposed	2020
Year Recommended	na
Companies	Ridgeback Biotherapeutics
Conditions Approved	Zaire ebolavirus infection
Conditions Active	na
Conditions Discontinued	na
Development Tech	na